These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2014553)

  • 1. Strain specificity in the induction of syngeneic graft-versus-host disease in mice.
    Bryson JS; Jennings CD; Caywood BE; Kaplan AM
    Transplantation; 1991 Apr; 51(4):911-3. PubMed ID: 2014553
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate TCR cells with self-reactive clones are effector cells which induce syngeneic graft-versus-host disease in mice.
    Osman Y; Watanabe T; Kawachi Y; Sato K; Ohtsuka K; Watanabe H; Hashimoto S; Moriyama Y; Shibata A; Abo T
    Cell Immunol; 1995 Dec; 166(2):172-86. PubMed ID: 7497519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.
    Sykes M; Bukhari Z; Sachs DH
    Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
    Eyrich M; Burger G; Marquardt K; Budach W; Schilbach K; Niethammer D; Schlegel PG
    Biol Blood Marrow Transplant; 2005 May; 11(5):371-82. PubMed ID: 15846291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice.
    Flanagan DL; Gross R; Jennings CD; Caywood BE; Goes S; Kaplan AM; Bryson JS
    J Leukoc Biol; 2001 Dec; 70(6):873-80. PubMed ID: 11739549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of long-term transplantation tolerance, chimerism, and host-versus-graft disease: interrelationship and cellular requirements.
    DeNardin AM; Brentjens JR; Andres GA; Nakamura I
    Transplant Proc; 1989 Feb; 21(1 Pt 1):265-6. PubMed ID: 2784894
    [No Abstract]   [Full Text] [Related]  

  • 10. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of syngeneic graft-versus-host disease by autosuppressor mechanisms.
    Hess AD; Fischer AC; Beschorner WE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3013-5. PubMed ID: 2523169
    [No Abstract]   [Full Text] [Related]  

  • 12. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
    Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
    Flanagan DL; Jennings CD; Bryson JS
    J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

  • 15. Syngeneic graft-vs-host disease.
    Ferrara JL
    Arch Dermatol; 1987 Jun; 123(6):741-2. PubMed ID: 3555352
    [No Abstract]   [Full Text] [Related]  

  • 16. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.
    Tutschka PJ; Berkowitz SD; Tuttle S; Klein J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease.
    Bryson JS; Caywood BE; Kaplan AM
    J Immunol; 1991 Jul; 147(2):391-7. PubMed ID: 2071889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease.
    Bryson JS; Jennings CD; Lowery DM; Carlson SL; Pflugh DL; Caywood BE; Kaplan AM
    Bone Marrow Transplant; 1999 Feb; 23(4):363-72. PubMed ID: 10100580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.